Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways
Context Sasanquasaponin (SQS) is a commonly used traditional Chinese medicine proved to have a wide range of pharmacological functions.Objective The objective of this study is to explore the effect and underlying mechanism of SQS in the treatment of prostate cancer (PC).Materials and methods PC cell...
Salvato in:
Autori principali: | Wenfeng Li (Autore), Yuanshen Mao (Autore), Bao Hua (Autore), Xin Gu (Autore), Chao Lu (Autore), Bin Xu (Autore), Weixin Pan (Autore) |
---|---|
Natura: | Libro |
Pubblicazione: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Soggetti: | |
Accesso online: | Connect to this object online. |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Documenti analoghi
-
Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
di: Nazanin Momeni Roudsari, et al.
Pubblicazione: (2021) -
Cucurbitacin B inhibits TGF-β1-induced epithelial-mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways
di: Renyikun Yuan, et al.
Pubblicazione: (2022) -
Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells
di: Wang F, et al.
Pubblicazione: (2015) -
Correction: Cucurbitacin B inhibits TGF-β1-induced epithelial-mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways
di: Renyikun Yuan, et al.
Pubblicazione: (2024) -
Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
di: Jieun Bang, et al.
Pubblicazione: (2023)